Avicanna Reports Q1 2023 Financial Statement
(marketscreener.com) TORONTO, May 16, 2023 — Avicanna Inc. , a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products, is pleased announce the filing of interim financial stateme…
TORONTO, May 16, 2023 (GLOBE NEWSWIRE) — Avicanna Inc. (“Avicanna” or the “Company “) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing, an…